Cassava Sciences, Inc. (SAVA)

2.80 -0.13 (-4.44%) USD  |  NASDAQ  |  Dec 15, 16:00
2.80 0.00 (0.00%) After-Hours: 20:00
More

Cassava Sciences Research and Development Expense (Annual): 69.64M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Biogen, Inc. 1.755B
Geron Corp. 103.74M
Ovid Therapeutics, Inc. 36.37M
NovaBay Pharmaceuticals, Inc. 0.042M
Palatin Technologies, Inc. 14.90M